Drug Trial Radar · NCT07838155
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease
Last checked: Nov 20, 2026Latest source record: Oct 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
50
Planned (sponsor's estimate)
Start
Nov 2026
Primary completion
Sep 2030
Study completion Sep 2030
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Sep 24, 2026
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 60 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this study is to assess how well Donanemab is tolerated and what side effects may occur in Indian participants with early symptoms of Alzheimer's Disease (AD). For each participant, the study will last up to approximately 84 weeks and will include visits every 4 weeks.
Conditions
- Alzheimer Disease
Interventions
DonanemabDrug
Donanemab administered IV
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants with Any Occurrence of Amyloid-Related Imaging Abnormalities (ARIA)Time frame: Baseline Up to Week 24, 52
- Frequency and Severity of Infusion-Related ReactionsTime frame: Through Week 52
Locations
12 sites in 1 country. Site status is shown where the registry gives one.
Manipal Hospital
Bangalore, India
NIMHANS
Bangalore, India
Aster CMI Hospital
Bangalore, India
Yashoda Hospital Somajiguda, Hyderabad
Hyderabad, India
Bangur Institute of Neurosciences (BIN) and Institute of Post Graduate Medical Education and Research (IPGME&R)
Kolkata, India
Apollo Multispeciality Hospitals limited
Kolkata, India
Kokilaben Dhirubhai Ambani Hospital & Medical Research Institute
Mumbai, India
Institute of Human Behaviour and Allied Sciences
New Delhi, India
All India Institute of Medical Sciences (AIIMS), New Delhi
New Delhi, India
Indraprastha Apollo Hospital
New Delhi, India
Apollo Speciality Hospital - Teynampet
Tamil Nadu, India
Christian Medical College Vellore
Vellore, India
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.